Market Value851,932,472
Total Holdings60
File Date2023-11-08
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
HCA / HCA Healthcare, Inc.
AVTR / Avantor, Inc.
UTHR / United Therapeutics Corporation
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
DHR / Danaher Corporation
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
ENSG / The Ensign Group, Inc.
TARO / Taro Pharmaceutical Industries Ltd.
ITCI / Intra-Cellular Therapies, Inc.
DXCM / DexCom, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
QGEN / Qiagen N.V.
AMRX / Amneal Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
73CSR / Concert Pharmaceuticals Inc
CLDX / Celldex Therapeutics, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
US33830X1046 / Five Prime Therapeutics Inc
XGN / Exagen Inc.
RAD / Rite Aid Corp.
/ Oxford Immunotec Global PLC
ONCT / Oncternal Therapeutics, Inc.
ZYME / Zymeworks Inc.
SLDB / Solid Biosciences Inc.
MRSN / Mersana Therapeutics, Inc.
OSUR / OraSure Technologies, Inc.
SRDX / Surmodics, Inc.
CTLT / Catalent, Inc.
ANAB / AnaptysBio, Inc.
SESN / Sesen Bio Inc.
ALT / Altimmune, Inc.
LQDA / Liquidia Corporation
BDSI / Biodelivery Sciences International
US62857M1053 / MyoKardia, Inc.
DVAX / Dynavax Technologies Corporation
US00C4U1L353 / Mylan N.V.
/ Solid Biosciences Inc
TLGT / Teligent Inc
MYOV / Myovant Sciences Ltd
AL / Air Lease Corporation
OSMT / Osmotica Pharmaceuticals Plc
PCRX / Pacira BioSciences, Inc.
GOCO / GoHealth, Inc.
SCPH / scPharmaceuticals Inc.
MODN / Model N, Inc.
AL / Air Lease Corporation
ZGNX / Zogenix Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MGLN / Magellan Health Inc
HSKA / Heska Corp. (Restricted Voting)
KDMN / Kadmon Holdings Inc
US60877T1007 / Momenta Pharmaceuticals, Inc.
ALBO / Albireo Pharma Inc
FLDM / Standard BioTools Inc
SNY / Sanofi - Depositary Receipt (Common Stock)
MCRB / Seres Therapeutics, Inc.
DRNA / Dicerna Pharmaceuticals Inc
PRTA / Prothena Corporation plc
TGTX / TG Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
A / Agilent Technologies, Inc.
NVST / Envista Holdings Corporation
GSK / GSK plc - Depositary Receipt (Common Stock)
GSK / GSK plc - Depositary Receipt (Common Stock) Call
AFMD / Affimed N.V.
VAPO / Vapotherm, Inc.
TARA / Protara Therapeutics, Inc.
QDEL / QuidelOrtho Corporation
BHVN / Biohaven Ltd.
DCPH / Deciphera Pharmaceuticals, Inc.
IQV / IQVIA Holdings Inc.
KALV / KalVista Pharmaceuticals, Inc.
CYH / Community Health Systems, Inc.
OTIC / Otonomy Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
MRUS / Merus N.V.
ELV / Elevance Health, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call